目次

1. Report Overview
1.1 Introduction to Biosimilars and Follow-on Biologics R&D Market
1.2 Biosimilars and Follow-on Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary
2.1 Europe Leading the Worldwide Biosimilars Market
2.1.1 Emerging Biopharmaceutical Companies to Drive Biosimilars Market Growth Further Over the Next Decade
2.1.2 The EU as a Gateway to Global Expansion
2.1.3 Growing Demand to Strategize Healthcare Costs to Offer Lucrative Growth Opportunities for Market Players

3 Market Dynamics
3.1 Drivers
3.1.1 Incentivizing Providers to Adopt Biosimilars
3.1.2 Developed Regions Driving the Worldwide Biosimilars and Follow-on Biologics Market Growth
3.1.3 Biologics Patent Expiry Set to Open Fresh Revenue Pockets for Biosimilars Companies Over the Next Decade
3.1.4 Pricing Advantage of Biosimilars Comparison to Biologics Anticipated to Fuel Market Growth Through 2031
3.2 Restraints
3.2.1 High Cost Involvement, Uncertainty and Complexities in Manufacturing
3.2.2 Resistance from Biologics Manufacturers to Restrain Market Growth
3.2.3 Reluctance of Healthcare Providers to Switch to Biosimilars
3.3 Opportunities
3.3.1 Companies Can Use Information of Original Innovator thus Shorten Development & Approval Processes
3.3.2 Diversity in Approach Among the Authorities
3.4 Challenges
3.4.1 Lack of Incentive Strategies Across Geographies Anticipated to Challenge Market Growth
3.4.2 Building Trust Among End-Users is a Challenge for Market Growth
3.5 Trends
3.5.1 Regulatory Hurdles Slowing Down Access to Biosimilars
3.5.2 Vulnerability of Global Pharmaceutical Manufacturing Amid COVID-19
3.5.3 Emerging Economies Continues to Pose Challenges for Building Presence for Generics and Biosimilars Companies
3.5.4 Digital Transformations as a Key Enabler to Strengthen Research in Biosimilars Industry
3.6 Porter’s Five Forces Analysis
3.6.1 Buyer Power
3.6.2 Supplier Power
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitute
3.6.5 Threat of New Entrants
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biosimilars and Follow-on Biologics Market
3.7.2 Economic Factors Impacting Biosimilars and Follow-on Biologics Market
3.7.3 Social Factors Impacting Biosimilars and Follow-on Biologics Market
3.7.4 Technological Factors Impacting Biosimilars and Follow-on Biologics Market

4 Biosimilars and Follow-on Biologics Market by Type of Manufacturing
4.1 Introduction
4.2 In-House Segment Market Forecast, 2021-2031
4.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 CMOs Segment Market Forecast, 2021-2031
4.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

5 Biosimilars and Follow-on Biologics Market by Type
5.1 Introduction
5.2 Monoclonal Antibodies Segment Market Forecast, 2021-2031
5.2.1 Monoclonal Antibodies Segment Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Fusion Proteins Segment Market Forecast, 2021-2031
5.3.1 Fusion Protein Segment Market Overview
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Insulin Segment Market Forecast, 2021-2031
5.4.1 Insulin Segment Market Overview
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Erythropoietin Segment Market Forecast, 2021-2031
5.5.1 Erythropoietin Segment Market Overview
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Granulocyte-Colony Stimulating Factor Segment Market Forecast, 2021-2031
5.6.1 G-CSF Segment Market Overview
5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.7 Interferon Segment Market Forecast, 2021-2031
5.7.1 Interferon Segment Market Overview
5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.8 Growth Hormones Segment Market Forecast, 2021-2031
5.8.1 Growth Hormones Segment Market Overview
5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.9 Fertility Hormones Segment Market Forecast, 2021-2031
5.9.1 Fertility Hormones Segment Market Overview
5.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.10 Others Segment Market Forecast, 2021-2031
5.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

6 Biosimilars and Follow-on Biologics Market by Application
6.1 Blood Disorders Segment Market Forecast, 2021-2031
6.1.1 Blood Disorders Segment Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Oncology Diseases Segment Market Forecast, 2021-2031
6.2.1 Oncology Diseases Segment Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Chronic & Autoimmune Diseases Segment Market Forecast, 2021-2031
6.3.1 Chronic & Autoimmune Diseases Segment Market Overview
6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 Growth Hormone Deficiencies Segment Market Forecast, 2021-2031
6.4.1 Growth Hormone Deficiencies Segment Market Overview
6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Others Segment Market Forecast, 2021-2031
6.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 Biosimilars and Follow-on Biologics Market by Technology
7.1 rDNA Technology Segment Market Forecast, 2021-2031
7.1.1 rDNA Technology Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 mAb Technology Segment Market Forecast, 2021-2031
7.2.1 mAb Technology Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Bioassay Technology Segment Market Forecast, 2021-2031
7.3.1 Bioassay Technology Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

8 Regional and Leading National Biosimilars and Follow-on Biologics Market Forecasts 2021-2031
8.1 Global Biosimilars and Follow-on Biologics Market by Region Forecast 2021-2031
8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

9 North America Biosimilars and Follow-on Biologics Market
9.1 North America Biosimilars and Follow-on Biologics Market by Country, Forecast 2021-2031
9.2 North America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing
9.3 North America Biosimilars and Follow-on Biologics Market Forecast by Type
9.4 North America Biosimilars and Follow-on Biologics Market Forecast by Application
9.5 North America Biosimilars and Follow-on Biologics Market Forecast by Technology
9.6 U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
9.6.1 United States is Just Beginning to Catch Up European Biosimilars Market
9.6.2 Rising Biosimilar Uptake to Fuel U.S. Biosimilars Market Growth
9.6.3 Advancements in Biosimilars Development and Approvals Across the United States to Fuel Market Growth
9.6.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
9.7 Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
9.7.1 Biosimilar Authorization Activity Across Canadian Region
9.7.2 Initiatives by Health Canada to Boost Canadian Biosimilars and Follow-on Biologics Market Over the Next Decade
9.7.3 Availability of Biosimilars in Oncology Treatment Landscape Driving Regional Growth
9.7.4 Canada Biosimilars and Follow-on Biologics Market Outlook
9.7.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031

10 Europe Biosimilars and Follow-on Biologics Market
10.1 Growing Prevalence of Lifestyle Diseases Anticipated to Fuel European Biosimilars Market Growth
10.2 Continued Benefits of Biosimilars to Offer Lucrative Growth Prospects in Long Term
10.3 Europe Biosimilars and Follow-on Biologics Market by Country, Forecast 2021-2031
10.4 Europe Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing
10.5 Europe Biosimilars and Follow-on Biologics Market Forecast by Type
10.6 Europe Biosimilars and Follow-on Biologics Market Forecast by Application
10.7 Europe Biosimilars and Follow-on Biologics Market Forecast by Technology
10.8 Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.8.1 Biosimilars Have Been Accepted as an Important Component of Proper Medication Usage in Germany
10.8.2 Germany Intends to Switch to Biologics Pharmacies by August 2022 thus Jeopardising the Long-Term Viability of Biosimilars
10.8.3 Germany Biosimilars and Follow-on Biologics Market Outlook
10.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.9 UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.9.1 NHS Encouraging the Growth of Biosimilar Manufacturing in United Kingdom?
10.9.2 Despite Price Reduction, Biosimilar Medications are not Widely Used in Retail Settings?
10.9.3 UK Biosimilars and Follow-on Biologics Market Outlook
10.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.10 France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.10.1 How is the Biosimilar Pricing Situation Across France?
10.10.2 Initiatives taken by French Government to Offer Lucrative Growth Prospects for Biosimilars Manufacturers Over the Forecast Period
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.11 Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.11.1 Italian Government Policies Anticipated to Fuel Development of Biosimilars Market Across the Region
10.11.2 Biosimilars to Help Reduce Price of Pharmaceuticals Across the Italian Region
10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.12 Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.12.1 Spain Biosimilars and Follow-on Biologics Market Outlook
10.12.2 Budget Impact Analysis of Biosimilar Products in Spain
10.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.13 Rest of Europe Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
10.13.1 Rest of Europe Biosimilars and Follow-on Biologics Market Outlook
10.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Biosimilars and Follow-on Biologics Market Forecast, 2021-2031

11 Asia Pacific Biosimilars and Follow-on Biologics Market
11.1 Low Clinical Development Costs Coupled with Regulatory Framework Ease to Fuel Regional Growth
11.2 Indian Pharmaceutical Companies Have an Enormous Scope in the Biosimilars Market
11.3 Asia Pacific Biosimilars and Follow-on Biologics Market by Country, Forecast 2021-2031
11.4 Asia Pacific Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing
11.5 Asia Pacific Biosimilars and Follow-on Biologics Market Forecast by Type
11.6 Asia Pacific Biosimilars and Follow-on Biologics Market Forecast by Application
11.7 Asia Pacific Biosimilars and Follow-on Biologics Market Forecast by Technology
11.8 Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.8.1 Biosimilars to Bolster Japanese Healthcare System Growth Over the Next Decade
11.8.2 Japan still has a slow growth in this sector compared to US and EU
11.8.3 Introduction of Biosimilars to Boost Regional Growth Through 2031
11.8.4 Ageing Japanese Population Demanding the Development of Biosimilars Over the Forecast Period
11.8.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.9 China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.9.1 Significant Surge in Biosimilar Approvals Over The Past 3 Years to Drive Market Growth
11.9.2 Technological Advancements to Fuel Chinese Biosimilars Market Growth Over the Forecast Period
11.9.3 Expansion by Major Firms to Boost Chinese Biosimilars Market Growth Through 2031
11.9.4 Overcrowding of Chinese Market Has Led to the Withdrawal of International Players
11.9.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.10 India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.10.1 India Set to Become Sixth Largest Pharmaceutical Market By End of 2030
11.10.2 Renowned Pharmaceutical Companies Establishing Partnerships with Indian Pharma Companies
11.10.3 India Biosimilars and Follow-on Biologics Market Outlook
11.10.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.11 Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
11.11.1 South Korean Biopharma Companies Jostling to Capture Significant Share of Asia Pacific Biosimilars Market
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031

12 Latin America Biosimilars and Follow-on Biologics Market
12.1 Latin America Biosimilars and Follow-on Biologics Market by Country, Forecast 2021-2031
12.2 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing
12.3 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type
12.4 Latin America Biosimilars and Follow-on Biologics Market Forecast by Application
12.5 Latin America Biosimilars and Follow-on Biologics Market Forecast by Technology
12.6 Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
12.6.1 Brazilian Biosimilars Regulations
12.6.2 Brazil Biosimilars and Follow-on Biologics Market Outlook
12.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
12.7 Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
12.7.1 Mexican Biosimilars Market to Offer Lucrative Growth Prospects Across Latin American Region
12.7.2 Mexico Biosimilars and Follow-on Biologics Market Outlook
12.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
12.8 Rest of Latin America Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
12.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Biosimilars and Follow-on Biologics Market Forecast, 2021-2031

13 Middle East and Africa Biosimilars and Follow-on Biologics Market
13.1 Middle East and Africa Biosimilars and Follow-on Biologics Market by Country, Forecast 2021-2031
13.2 MEA Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing
13.3 MEA Biosimilars and Follow-on Biologics Market Forecast by Type
13.4 MEA Biosimilars and Follow-on Biologics Market Forecast by Application
13.5 MEA Biosimilars and Follow-on Biologics Market Forecast by Technology
13.6 GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
13.6.1 GCC Gearing Up to Take Big Jump on Biosimilars
13.6.2 Collaborations Among Pharmaceutical Firms Across GCC to Offer Lucrative Growth Prospects for Market Players Over the Forecast Period
13.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
13.7 South Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
13.7.1 South African Evolving Demographic and Epidemiological Profile to Offer Lucrative Growth Prospects
13.7.2 Presence of Major Pharmaceutical Firms to Intensify Competition
13.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
13.8 Rest of Middle East and Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031
13.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031

14 Company Profiles
14.1 Biosimilars Company Ranking, 2020
14.2 3SBio, Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Product Benchmarking
14.2.4 Recent Developments
14.3 AMEGA Biotech
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.4 Amgen Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 Apotex, Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.6 BIOCAD
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Product Benchmarking
14.6.4 Recent Developments
14.7 Biocon Limited
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Biogen, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.9 Celltrion Healthcare Co.,Ltd.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.9.4 Recent Developments
14.10 Coherus BioSciences
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Recent Developments
14.11 Dr. Reddy’s Laboratories Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 Eli Lilly and Company
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Gedeon Richter PLC
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Recent Developments
14.14 Intas Pharmaceutical Ltd.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Mabxience SA
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.15.4 Recent Developments
14.16 Viatris Inc. (Mylan NV)
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.16.5 Recent Developments
14.17 Novartis AG
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.17.5 Recent Developments
14.18 Pfizer Inc.
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.4 Product Benchmarking
14.18.5 Recent Developments
14.19 Samsung Bioepis Co. Ltd.
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Product Benchmarking
14.19.4 Recent Developments
14.20 Stada Arzneimittel AG
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis
14.20.4 Product Benchmarking
14.20.5 Recent Developments
14.21 Teva Pharmaceutical
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Financial Analysis
14.21.4 Product Benchmarking
14.21.5 Recent Developments

15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations
15.3 Europe Leading the Global Biosimilars Market

List of Tables
Table 1 Global Biosimilars and Follow-on Biologics Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Biosimilars and Follow-on Biologics Market Forecast for In-House Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global Biosimilars and Follow-on Biologics Market Forecast for In-House Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Biosimilars and Follow-on Biologics Market Forecast for In-House Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Biosimilars and Follow-on Biologics Market Forecast for In-House Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Biosimilars and Follow-on Biologics Market Forecast for In-House Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Biosimilars and Follow-on Biologics Market Forecast for CMOs Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global Biosimilars and Follow-on Biologics Market Forecast for CMOs Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Biosimilars and Follow-on Biologics Market Forecast for CMOs Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Biosimilars and Follow-on Biologics Market Forecast for CMOs Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Biosimilars and Follow-on Biologics Market Forecast for CMOs Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global Biosimilars and Follow-on Biologics Market Forecast for Monoclonal Antibodies Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 15 Global Biosimilars and Follow-on Biologics Market Forecast for Monoclonal Antibodies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biosimilars and Follow-on Biologics Market Forecast for Monoclonal Antibodies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biosimilars and Follow-on Biologics Market Forecast for Monoclonal Antibodies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biosimilars and Follow-on Biologics Market Forecast for Monoclonal Antibodies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biosimilars and Follow-on Biologics Market Forecast for Fusion Proteins Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global Biosimilars and Follow-on Biologics Market Forecast for Fusion Proteins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biosimilars and Follow-on Biologics Market Forecast for Fusion Proteins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biosimilars and Follow-on Biologics Market Forecast for Fusion Proteins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biosimilars and Follow-on Biologics Market Forecast for Fusion Proteins Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biosimilars and Follow-on Biologics Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global Biosimilars and Follow-on Biologics Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biosimilars and Follow-on Biologics Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biosimilars and Follow-on Biologics Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biosimilars and Follow-on Biologics Market Forecast for Insulin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biosimilars and Follow-on Biologics Market Forecast for Erythropoietin Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global Biosimilars and Follow-on Biologics Market Forecast for Erythropoietin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Biosimilars and Follow-on Biologics Market Forecast for Erythropoietin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Biosimilars and Follow-on Biologics Market Forecast for Erythropoietin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Biosimilars and Follow-on Biologics Market Forecast for Erythropoietin Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Biosimilars and Follow-on Biologics Market Forecast for Granulocyte-Colony Stimulating Factor Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global Biosimilars and Follow-on Biologics Market Forecast for Granulocyte-Colony Stimulating Factor Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Global Biosimilars and Follow-on Biologics Market Forecast for Granulocyte-Colony Stimulating Factor Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Global Biosimilars and Follow-on Biologics Market Forecast for Granulocyte-Colony Stimulating Factor Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Global Biosimilars and Follow-on Biologics Market Forecast for Granulocyte-Colony Stimulating Factor Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Global Biosimilars and Follow-on Biologics Market Forecast for Interferon Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 40 Global Biosimilars and Follow-on Biologics Market Forecast for Interferon Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Biosimilars and Follow-on Biologics Market Forecast for Interferon Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Biosimilars and Follow-on Biologics Market Forecast for Interferon Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Biosimilars and Follow-on Biologics Market Forecast for Interferon Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 45 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Biosimilars and Follow-on Biologics Market Forecast for Fertility Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Biosimilars and Follow-on Biologics Market Forecast for Fertility Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Global Biosimilars and Follow-on Biologics Market Forecast for Fertility Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Global Biosimilars and Follow-on Biologics Market Forecast for Fertility Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Global Biosimilars and Follow-on Biologics Market Forecast for Fertility Hormones Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Global Biosimilars and Follow-on Biologics Market Forecast for Blood Disorders Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global Biosimilars and Follow-on Biologics Market Forecast for Blood Disorders Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Biosimilars and Follow-on Biologics Market Forecast for Blood Disorders Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Biosimilars and Follow-on Biologics Market Forecast for Blood Disorders Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Biosimilars and Follow-on Biologics Market Forecast for Blood Disorders Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Biosimilars and Follow-on Biologics Market Forecast for Oncology Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 66 Global Biosimilars and Follow-on Biologics Market Forecast for Oncology Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Biosimilars and Follow-on Biologics Market Forecast for Oncology Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Biosimilars and Follow-on Biologics Market Forecast for Oncology Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Biosimilars and Follow-on Biologics Market Forecast for Oncology Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Biosimilars and Follow-on Biologics Market Forecast for Chronic & Autoimmune Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 71 Global Biosimilars and Follow-on Biologics Market Forecast for Chronic & Autoimmune Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Biosimilars and Follow-on Biologics Market Forecast for Chronic & Autoimmune Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Biosimilars and Follow-on Biologics Market Forecast for Chronic & Autoimmune Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Biosimilars and Follow-on Biologics Market Forecast for Chronic & Autoimmune Diseases Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormone Deficiencies Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 76 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormone Deficiencies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 77 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormone Deficiencies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 78 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormone Deficiencies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 79 Global Biosimilars and Follow-on Biologics Market Forecast for Growth Hormone Deficiencies Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 80 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 81 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 82 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 83 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 84 Global Biosimilars and Follow-on Biologics Market Forecast for Others Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 85 Global Biosimilars and Follow-on Biologics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 86 Global Biosimilars and Follow-on Biologics Market Forecast for rDNA Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 Global Biosimilars and Follow-on Biologics Market Forecast for rDNA Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 Global Biosimilars and Follow-on Biologics Market Forecast for rDNA Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 Global Biosimilars and Follow-on Biologics Market Forecast for rDNA Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 Global Biosimilars and Follow-on Biologics Market Forecast for rDNA Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 Global Biosimilars and Follow-on Biologics Market Forecast for Mab Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 92 Global Biosimilars and Follow-on Biologics Market Forecast for Mab Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 Global Biosimilars and Follow-on Biologics Market Forecast for Mab Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 Global Biosimilars and Follow-on Biologics Market Forecast for Mab Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 Global Biosimilars and Follow-on Biologics Market Forecast for Mab Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Global Biosimilars and Follow-on Biologics Market Forecast for Bioassay Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 97 Global Biosimilars and Follow-on Biologics Market Forecast for Bioassay Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Global Biosimilars and Follow-on Biologics Market Forecast for Bioassay Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Global Biosimilars and Follow-on Biologics Market Forecast for Bioassay Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Global Biosimilars and Follow-on Biologics Market Forecast for Bioassay Technology Segment, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Global Biosimilars and Follow-on Biologics Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 102 Global Biosimilars and Follow-on Biologics Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 103 Global Biosimilars and Follow-on Biologics Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 104 Global Biosimilars and Follow-on Biologics Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 105 Global Biosimilars and Follow-on Biologics Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 106 North America Biosimilars and Follow-on Biologics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 107 North America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 108 North America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 North America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 North America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 North America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 North America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 113 North America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 North America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 North America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 North America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 North America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 118 North America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 North America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 North America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 North America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 North America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 123 North America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 North America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 North America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 North America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 Biosimilars Launched in the United States as of December 2020
Table 128 Biosimilars Approved in the United States
Table 129 U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 130 U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 131 U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 132 U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 133 U.S. Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 134 Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 135 Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 136 Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 137 Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 138 Canada Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 139 Europe Biosimilars and Follow-on Biologics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 140 Europe Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 141 Europe Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Europe Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Europe Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Europe Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 145 Europe Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 146 Europe Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 147 Europe Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 148 Europe Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 149 Europe Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 150 Europe Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 151 Europe Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 152 Europe Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 153 Europe Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 154 Europe Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 155 Europe Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 156 Europe Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 157 Europe Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 158 Europe Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 159 Europe Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 160 Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 161 Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 162 Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 163 Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 164 Germany Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 165 UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 166 UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 167 UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 168 UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 169 UK Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 170 France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 171 France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 172 France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 173 France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 174 France Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 175 Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 176 Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 177 Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 178 Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 179 Italy Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 180 Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 181 Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 182 Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 183 Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 184 Spain Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 185 Rest of Europe Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 186 Rest of Europe Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 187 Rest of Europe Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 188 Rest of Europe Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 189 APAC Biosimilars and Follow-on Biologics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 190 APAC Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 191 APAC Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 192 APAC Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 193 APAC Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 194 APAC Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 195 APAC Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 196 APAC Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 197 APAC Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 198 APAC Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 199 APAC Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 200 APAC Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 201 APAC Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 202 APAC Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 203 APAC Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 204 APAC Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 205 APAC Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 206 APAC Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 207 APAC Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 208 APAC Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 209 APAC Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 210 Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 211 Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 212 Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 213 Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 214 Japan Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 215 China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 216 China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 217 China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 218 China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 219 China Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 220 India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 221 India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 222 India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 223 India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 224 India Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 225 Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 227 Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 228 Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 229 Rest of Asia Pacific Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 230 LATAM Biosimilars and Follow-on Biologics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 231 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 232 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 233 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 234 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 235 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 236 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 237 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 238 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 239 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 240 Latin America Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 241 Latin America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 242 Latin America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 243 Latin America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 244 Latin America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 245 Latin America Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 246 Latin America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 247 Latin America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 248 Latin America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 249 Latin America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 250 Latin America Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 251 Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 252 Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 253 Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 254 Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 255 Brazil Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 256 Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 257 Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 258 Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 259 Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 260 Mexico Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 261 Rest of Latin America Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 262 Rest of Latin America Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 263 Rest of Latin America Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 264 Rest of Latin America Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 265 MEA Biosimilars and Follow-on Biologics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 266 MEA Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 267 MEA Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 268 MEA Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 269 MEA Biosimilars and Follow-on Biologics Market Forecast by Type of Manufacturing, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 270 MEA Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 271 MEA Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 272 MEA Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 273 MEA Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 274 MEA Biosimilars and Follow-on Biologics Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 275 MEA Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 276 MEA Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 277 MEA Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 278 MEA Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 279 MEA Biosimilars and Follow-on Biologics Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 280 MEA Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 281 MEA Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 282 MEA Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 283 MEA Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 284 MEA Biosimilars and Follow-on Biologics Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 285 GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 286 GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 287 GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 288 GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 289 GCC Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 290 South Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 291 South Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 292 South Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 293 South Africa Biosimilars and Follow-on Biologics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Sha